Abstract: TH-PO665
Predictors for 1-Year Mortality Among Elderly Patients with CKD Stage 4 and 5 Initiated on Hemodialysis at Divine Word Hospital, Tacloban City, Philippines, 2014-2016
Session Information
- Geriatric Nephrology
November 07, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Geriatric Nephrology
- 1100 Geriatric Nephrology
Author
- Matoza-Serna, Joyce Rosario Asis, Divine Word Hospital, Tacloban City, Leyte, Philippines
Background
Chronic kidney disease (CKD) prevalence among the elderly patients is increasing. This study aimed to describe the clinical and demographic profile of the elderly patients with CKD Stages 4 and 5; to determine the 1 year outcomes after HD initiation as to survival, death and its causes of mortality and to identify the predictors for 1 year-mortality among elderly CKD patients.
Methods
A descriptive retrospective study involving all elderly patients diagnosed with CKD Stage 4 and 5 initiated on hemodialysis at Divine Word Hospital in the year 2014 to 2016. Patients’ demographic and clinical data, and the outcomes on hemodialysis in the form of 1-year survival or death were identified. Data were analyzed with the use of frequency distribution and percentages for categorical variables, and mean and standard deviation for continuous variables. Univariate cox regression was employed to identify the predictors of mortality.
Results
Eighty three participants were included in the study. The mean age was 73 years old, females comprised 56%, Dabetic Kidney Disease accounted to 58%, cardiovascular and metabolic co-mobidities were present in 91% and 65% of cases, respectively; and majority had no presume pre-HD nephrology care at 56%. Seventy five percent survived after 1 year from HD initiation. Female gender and hemoglobin level of <10 g/dL were significant predictors of mortality.
Conclusion
The predictors for 1 year-mortality among elderly patients with CKD stage 4 and 5 initiated on hemodialysis were female gender and anemia (hemoglobin of <10g/dL). Specific measures to address these risk factors must be implemented to improve survival in these patients.